Literature DB >> 30926672

Hypoxia-induced Changes in SUMO Conjugation Affect Transcriptional Regulation Under Low Oxygen.

Georgia Chachami1,2, Nicolas Stankovic-Valentin3, Angeliki Karagiota4, Angeliki Basagianni4, Uwe Plessmann5, Henning Urlaub5,6, Frauke Melchior3, George Simos4,7.   

Abstract

Hypoxia occurs in pathological conditions, such as cancer, as a result of the imbalance between oxygen supply and consumption by proliferating cells. HIFs are critical molecular mediators of the physiological response to hypoxia but also regulate multiple steps of carcinogenesis including tumor progression and metastasis. Recent data support that sumoylation, the covalent attachment of the Small Ubiquitin-related MOdifier (SUMO) to proteins, is involved in the activation of the hypoxic response and the ensuing signaling cascade. To gain insights into differences of the SUMO1 and SUMO2/3 proteome of HeLa cells under normoxia and cells grown for 48 h under hypoxic conditions, we employed endogenous SUMO-immunoprecipitation in combination with quantitative mass spectrometry (SILAC). The group of proteins whose abundance was increased both in the total proteome and in the SUMO IPs from hypoxic conditions was enriched in enzymes linked to the hypoxic response. In contrast, proteins whose SUMOylation status changed without concomitant change in abundance were predominantly transcriptions factors or transcription regulators. Particularly interesting was transcription factor TFAP2A (Activating enhancer binding Protein 2 alpha), whose sumoylation decreased on hypoxia. TFAP2A is known to interact with HIF-1 and we provide evidence that deSUMOylation of TFAP2A enhances the transcriptional activity of HIF-1 under hypoxic conditions. Overall, these results support the notion that SUMO-regulated signaling pathways contribute at many distinct levels to the cellular response to low oxygen.
© 2019 Chachami et al.

Entities:  

Keywords:  Cell biology*; HIF; HIF-1α; Hypoxia; Mass Spectrometry; Molecular biology*; Post-translational modifications*; SILAC; SUMO; TFAP2A; Transcriptional Regulation*

Mesh:

Substances:

Year:  2019        PMID: 30926672      PMCID: PMC6553927          DOI: 10.1074/mcp.RA119.001401

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  55 in total

Review 1.  Functional and quantitative proteomics using SILAC.

Authors:  Matthias Mann
Journal:  Nat Rev Mol Cell Biol       Date:  2006-12       Impact factor: 94.444

Review 2.  Concepts in sumoylation: a decade on.

Authors:  Ruth Geiss-Friedlander; Frauke Melchior
Journal:  Nat Rev Mol Cell Biol       Date:  2007-12       Impact factor: 94.444

3.  Ubiquitin-specific protease-like 1 (USPL1) is a SUMO isopeptidase with essential, non-catalytic functions.

Authors:  Sarah Schulz; Georgia Chachami; Lukasz Kozaczkiewicz; Ulrike Winter; Nicolas Stankovic-Valentin; Petra Haas; Kay Hofmann; Henning Urlaub; Huib Ovaa; Joachim Wittbrodt; Erik Meulmeester; Frauke Melchior
Journal:  EMBO Rep       Date:  2012-08-10       Impact factor: 8.807

4.  Ubc9 acetylation modulates distinct SUMO target modification and hypoxia response.

Authors:  Yung-Lin Hsieh; Hong-Yi Kuo; Che-Chang Chang; Mandar T Naik; Pei-Hsin Liao; Chun-Chen Ho; Tien-Chi Huang; Jen-Chong Jeng; Pang-Hung Hsu; Ming-Daw Tsai; Tai-Huang Huang; Hsiu-Ming Shih
Journal:  EMBO J       Date:  2013-02-08       Impact factor: 11.598

5.  Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.

Authors:  Amy B Heimberger; Eric C McGary; Dima Suki; Maribelis Ruiz; Huamin Wang; Gregory N Fuller; Menashe Bar-Eli
Journal:  Clin Cancer Res       Date:  2005-01-01       Impact factor: 12.531

6.  Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.

Authors:  Ivo A Hendriks; David Lyon; Clifford Young; Lars J Jensen; Alfred C O Vertegaal; Michael L Nielsen
Journal:  Nat Struct Mol Biol       Date:  2017-01-23       Impact factor: 15.369

7.  Sumo-2/3-ylation following in vitro modeled ischemia is reduced in delayed ischemic tolerance.

Authors:  Liam T Loftus; Rosaria Gala; Tao Yang; Veronica J Jessick; Michelle D Ashley; Andrea N Ordonez; Simon J Thompson; Roger P Simon; Robert Meller
Journal:  Brain Res       Date:  2009-03-28       Impact factor: 3.252

8.  System-wide Analysis of SUMOylation Dynamics in Response to Replication Stress Reveals Novel Small Ubiquitin-like Modified Target Proteins and Acceptor Lysines Relevant for Genome Stability.

Authors:  Zhenyu Xiao; Jer-Gung Chang; Ivo A Hendriks; Jón Otti Sigurðsson; Jesper V Olsen; Alfred C O Vertegaal
Journal:  Mol Cell Proteomics       Date:  2015-03-09       Impact factor: 5.911

9.  Proteome-wide identification of SUMO2 modification sites.

Authors:  Triin Tammsalu; Ivan Matic; Ellis G Jaffray; Adel F M Ibrahim; Michael H Tatham; Ronald T Hay
Journal:  Sci Signal       Date:  2014-04-29       Impact factor: 8.192

10.  Molecular characterization of the SUMO-1 modification of RanGAP1 and its role in nuclear envelope association.

Authors:  R Mahajan; L Gerace; F Melchior
Journal:  J Cell Biol       Date:  1998-01-26       Impact factor: 10.539

View more
  8 in total

Review 1.  The Function of SUMOylation and Its Role in the Development of Cancer Cells under Stress Conditions: A Systematic Review.

Authors:  Qi Zhao; Ying Ma; Zugui Li; Kexin Zhang; Minying Zheng; Shiwu Zhang
Journal:  Stem Cells Int       Date:  2020-11-13       Impact factor: 5.443

2.  Astragaloside IV improves angiogenesis under hypoxic conditions by enhancing hypoxia‑inducible factor‑1α SUMOylation.

Authors:  Baoshen Wang; Chunyan Zhang; Dongmei Chu; Xiaofang Ma; Tian Yu; Xiaozhi Liu; Changqing Hu
Journal:  Mol Med Rep       Date:  2021-02-04       Impact factor: 2.952

Review 3.  Roles of HIF and 2-Oxoglutarate-Dependent Dioxygenases in Controlling Gene Expression in Hypoxia.

Authors:  Julianty Frost; Mark Frost; Michael Batie; Hao Jiang; Sonia Rocha
Journal:  Cancers (Basel)       Date:  2021-01-19       Impact factor: 6.639

4.  The Sumo proteome of proliferating and neuronal-differentiating cells reveals Utf1 among key Sumo targets involved in neurogenesis.

Authors:  Juan F Correa-Vázquez; Francisco Juárez-Vicente; Pablo García-Gutiérrez; Sina V Barysch; Frauke Melchior; Mario García-Domínguez
Journal:  Cell Death Dis       Date:  2021-03-22       Impact factor: 8.469

5.  Hypoxia-induced HIF1α activation regulates small extracellular vesicle release in human embryonic kidney cells.

Authors:  Ana Muñiz-García; Montserrat Romero; Juan Manuel Falcόn-Perez; Patricia Murray; Antonio Zorzano; Silvia Mora
Journal:  Sci Rep       Date:  2022-01-27       Impact factor: 4.379

Review 6.  The Role of Sumoylation in the Response to Hypoxia: An Overview.

Authors:  Chrysa Filippopoulou; George Simos; Georgia Chachami
Journal:  Cells       Date:  2020-10-26       Impact factor: 6.600

7.  Diagnostic Potential of Exosomal HypoxamiRs in the Context of Hypoxia-Sumoylation-HypoxamiRs in Early Onset Preeclampsia at the Preclinical Stage.

Authors:  Vladislava Gusar; Angelika Timofeeva; Vitaliy Chagovets; Nataliya Kan; Mikhail Vysokikh; Maria Marey; Anna Karapetyan; Oleg Baev; Gennadiy Sukhikh
Journal:  Life (Basel)       Date:  2022-01-11

Review 8.  Systems approaches to understand oxygen sensing: how multi-omics has driven advances in understanding oxygen-based signalling.

Authors:  Michael Batie; Niall S Kenneth; Sonia Rocha
Journal:  Biochem J       Date:  2022-02-11       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.